p53 mutations associated with aging-related rise in cancer incidence rates

References

• Lane DP. Cancer. p53, guardian of the genome. Nature 1992; 358:15 - 6; http://dx.doi.org/10.1038/358015a0; PMID: 1614522
   PubMed Web of Science ®Google Scholar
• Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253:49 - 53; http://dx.doi.org/10.1126/science.1905840; PMID: 1905840
   PubMed Web of Science ®Google Scholar
• Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 2002; 19:607 - 14; http://dx.doi.org/10.1002/humu.10081; PMID: 12007217
   PubMed Web of Science ®Google Scholar
• Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002; 415:45 - 53; http://dx.doi.org/10.1038/415045a; PMID: 11780111
   PubMed Web of Science ®Google Scholar
• Rodier F, Campisi J, Bhaumik D. Two faces of p53: aging and tumor suppression. Nucleic Acids Res 2007; 35:7475 - 84; http://dx.doi.org/10.1093/nar/gkm744; PMID: 17942417
   PubMed Web of Science ®Google Scholar
• Efeyan A, Serrano M. p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 2007; 6:1006 - 10; http://dx.doi.org/10.4161/cc.6.9.4211; PMID: 17457049
   PubMed Web of Science ®Google Scholar
• Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY) 2010; 2:344 - 52; PMID: 20606252
   PubMedGoogle Scholar
• Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993; 53:4477 - 80; PMID: 8402617
   PubMed Web of Science ®Google Scholar
• Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445:661 - 5; http://dx.doi.org/10.1038/nature05541; PMID: 17251932
   PubMed Web of Science ®Google Scholar
• Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445:656 - 60; http://dx.doi.org/10.1038/nature05529; PMID: 17251933
   PubMed Web of Science ®Google Scholar
• Chilosi M, Doglioni C, Menestrina F, Montagna L, Rigo A, Lestani M, et al. Abnormal expression of the p53-binding protein MDM2 in Hodgkin’s disease. Blood 1994; 84:4295 - 300; PMID: 7994045
   PubMed Web of Science ®Google Scholar
• Goffin JR, Chappuis PO, Bégin LR, Wong N, Brunet JS, Hamel N, et al. Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data. Cancer 2003; 97:527 - 36; http://dx.doi.org/10.1002/cncr.11080; PMID: 12548593
   PubMed Web of Science ®Google Scholar
• Stubbert LJ, Smith JM, Hamill JD, Arcand TL, McKay BC. The anti-apoptotic role for p53 following exposure to ultraviolet light does not involve DDB2. Mutat Res 2009; 663:69 - 76; http://dx.doi.org/10.1016/j.mrfmmm.2009.01.010; PMID: 19428372
   PubMed Web of Science ®Google Scholar
• Canadian Cancer Society’s Steering Committee on Cancer Statistics. (2011). Canadian Cancer Statistics 2011. (Toronto, ON: Canadian Cancer Society).
   Google Scholar
• Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954; 8:1 - 12; http://dx.doi.org/10.1038/bjc.1954.1; PMID: 13172380
   PubMed Web of Science ®Google Scholar
• Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 2005; 34:405 - 12; http://dx.doi.org/10.1093/ije/dyh414; PMID: 15737977
   PubMed Web of Science ®Google Scholar
• Liu B, Fan Z, Edgerton SM, Deng XS, Alimova IN, Lind SE, et al. Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle 2009; 8:2031 - 40; http://dx.doi.org/10.4161/cc.8.13.8814; PMID: 19440038
   PubMed Web of Science ®Google Scholar
• Hainaut P, Wiman KG. 30 years and a long way into p53 research. Lancet Oncol 2009; 10:913 - 9; http://dx.doi.org/10.1016/S1470-2045(09)70198-6; PMID: 19717093
   PubMed Web of Science ®Google Scholar
• Ghartimagar D, Naik R, Gupta A, Ghosh A. A. Histopathology of prostatic lesions – an autopsy study of 100 cases. The Internet Journal of Forensic Science 2012; 5; http://dx.doi.org/10.1016/j.ccr.2010.09.005; PMID: 20951946
   PubMedGoogle Scholar
• Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet 2011; 377:557 - 67; http://dx.doi.org/10.1016/S0140-6736(10)62037-5; PMID: 21295846
   PubMed Web of Science ®Google Scholar
• Toyooka S, Tsuda T, Gazdar AF. The TP53 gene, tobacco exposure, and lung cancer. Hum Mutat 2003; 21:229 - 39; http://dx.doi.org/10.1002/humu.10177; PMID: 12619108
   PubMed Web of Science ®Google Scholar
• Hill AB. The environment and disease: association or causation?. Proc R Soc Med 1965; 58:295 - 300; PMID: 14283879
   PubMed Web of Science ®Google Scholar
• Höfler M. The Bradford Hill considerations on causality: a counterfactual perspective. Emerg Themes Epidemiol 2005; 2:11; http://dx.doi.org/10.1186/1742-7622-2-11; PMID: 16269083
   PubMedGoogle Scholar
• Malkin D. Li-Fraumeni syndrome. Genes Cancer 2011; 2:475 - 84; http://dx.doi.org/10.1177/1947601911413466; PMID: 21779515
   PubMedGoogle Scholar
• Jerry DJ, Ozbun MA, Kittrell FS, Lane DP, Medina D, Butel JS. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development. Cancer Res 1993; 53:3374 - 81; PMID: 8324748
   PubMed Web of Science ®Google Scholar
• Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 1994; 54:4342 - 6; PMID: 8044781
   PubMed Web of Science ®Google Scholar
• Morgan C, Jenkins GJ, Ashton T, Griffiths AP, Baxter JN, Parry EM, et al. Detection of p53 mutations in precancerous gastric tissue. Br J Cancer 2003; 89:1314 - 9; http://dx.doi.org/10.1038/sj.bjc.6601302; PMID: 14520466
   PubMed Web of Science ®Google Scholar
• Petitjean A, Achatz MIW, Borresen-Dale AL, Hainaut P, Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 2007; 26:2157 - 65; http://dx.doi.org/10.1038/sj.onc.1210302; PMID: 17401424
   PubMed Web of Science ®Google Scholar
• Matoba S, Kang J-G, Patino WD, Wragg A, Boehm M, Gavrilova O, et al. p53 regulates mitochondrial respiration. Science 2006; 312:1650 - 3; http://dx.doi.org/10.1126/science.1126863; PMID: 16728594
   PubMed Web of Science ®Google Scholar
• Sood AK, Skilling JS, Buller RE. Ovarian cancer genomic instability correlates with p53 frameshift mutations. Cancer Res 1997; 57:1047 - 9; PMID: 9067268
   PubMed Web of Science ®Google Scholar
• Shahedian B, Shi YF, Zou MJ, Farid NR. Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations. Mol Genet Metab 2001; 72:155 - 63; http://dx.doi.org/10.1006/mgme.2000.3114; PMID: 11161841
   PubMed Web of Science ®Google Scholar
• Schmitt CA, Fridman JS, Yang M, Baranov E, Hoffman RM, Lowe SW. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 2002; 1:289 - 98; http://dx.doi.org/10.1016/S1535-6108(02)00047-8; PMID: 12086865
   PubMed Web of Science ®Google Scholar
• Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr., Butel JS, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356:215 - 21; http://dx.doi.org/10.1038/356215a0; PMID: 1552940
   PubMed Web of Science ®Google Scholar
• Mitchel RE, Jackson JS, Morrison DP, Carlisle SM. Low doses of radiation increase the latency of spontaneous lymphomas and spinal osteosarcomas in cancer-prone, radiation-sensitive Trp53 heterozygous mice. Radiat Res 2003; 159:320 - 7; http://dx.doi.org/10.1667/0033-7587(2003)159[0320:LDORIT]2.0.CO;2; PMID: 12600234
   PubMed Web of Science ®Google Scholar
• Parton M, Dowsett M, Smith I. Studies of apoptosis in breast cancer. BMJ 2001; 322:1528 - 32; http://dx.doi.org/10.1136/bmj.322.7301.1528; PMID: 11420276
   PubMed Web of Science ®Google Scholar
• Mai S, Hanley-Hyde J, Rainey GJ, Kuschak TI, Paul JT, Littlewood TD, et al. Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression. Neoplasia 1999; 1:241 - 52; http://dx.doi.org/10.1038/sj.neo.7900030; PMID: 10935479
   PubMedGoogle Scholar
• Abulaiti A, Fikaris AJ, Tsygankova OM, Meinkoth JL. Ras induces chromosome instability and abrogation of the DNA damage response. Cancer Res 2006; 66:10505 - 12; http://dx.doi.org/10.1158/0008-5472.CAN-06-2351; PMID: 17079472
   PubMed Web of Science ®Google Scholar
• Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371:569 - 78; http://dx.doi.org/10.1016/S0140-6736(08)60269-X; PMID: 18280327
   PubMed Web of Science ®Google Scholar
• Feng Z, Jin S, Zupnick A, Hoh J, de Stanchina E, Lowe S, et al. p53 tumor suppressor protein regulates the levels of huntingtin gene expression. Oncogene 2006; 25:1 - 7; PMID: 16278683
   PubMed Web of Science ®Google Scholar
• Chen Z, Trotman LC, Shaffer D, Lin H-K, Dotan ZA, Niki M, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005; 436:725 - 30; http://dx.doi.org/10.1038/nature03918; PMID: 16079851
   PubMed Web of Science ®Google Scholar
• Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 2010; 18:367 - 81; http://dx.doi.org/10.1016/j.ccr.2010.09.005; PMID: 20951946
   PubMed Web of Science ®Google Scholar
• Fulci G, Ishii N, Van Meir EG. p53 and brain tumors: from gene mutations to gene therapy. Brain Pathol 1998; 8:599 - 613; http://dx.doi.org/10.1111/j.1750-3639.1998.tb00187.x; PMID: 9804370
   PubMed Web of Science ®Google Scholar
• Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 2009; 361:2449 - 60; http://dx.doi.org/10.1056/NEJMra0804588; PMID: 20018966
   PubMed Web of Science ®Google Scholar
• Zhu Y-M, Foroni L, McQuaker IG, Papaioannou M, Haynes A, Russell HH. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia. Br J Cancer 1999; 79:1151 - 7; http://dx.doi.org/10.1038/sj.bjc.6690183; PMID: 10098750
   PubMed Web of Science ®Google Scholar
• Richardson RB. Ionizing radiation and aging: rejuvenating an old idea. Aging (Albany NY) 2009; 1:887 - 902; PMID: 20157573
   PubMedGoogle Scholar
• Richardson RB. Stem cell niches and other factors that influence the sensitivity of bone marrow to radiation-induced bone cancer and leukaemia in children and adults. Int J Radiat Biol 2011; 87:343 - 59; http://dx.doi.org/10.3109/09553002.2010.537430; PMID: 21204614
   PubMed Web of Science ®Google Scholar
• Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396:643 - 9; http://dx.doi.org/10.1038/25292; PMID: 9872311
   PubMed Web of Science ®Google Scholar
• Feng ZH, Hu WW, Teresky AK, Hernando E, Cordon-Cardo C, Levine AJ. Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations. Proc Natl Acad Sci U S A 2007; 104:16633 - 8; http://dx.doi.org/10.1073/pnas.0708043104; PMID: 17921246
   PubMed Web of Science ®Google Scholar
• Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446:153 - 8; http://dx.doi.org/10.1038/nature05610; PMID: 17344846
   PubMed Web of Science ®Google Scholar
• Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science 2011; 331:1553 - 8; http://dx.doi.org/10.1126/science.1204040; PMID: 21436442
   PubMed Web of Science ®Google Scholar
• Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007; 318:1108 - 13; http://dx.doi.org/10.1126/science.1145720; PMID: 17932254
   PubMed Web of Science ®Google Scholar
• Shepard JL, Amatruda JF, Finkelstein D, Ziai J, Finley KR, Stern HM, et al. A mutation in separase causes genome instability and increased susceptibility to epithelial cancer. Genes Dev 2007; 21:55 - 9; http://dx.doi.org/10.1101/gad.1470407; PMID: 17210788
   PubMed Web of Science ®Google Scholar
• Donehower LA. Genetic instability in animal tumorigenesis models. Cancer Surv 1997; 29:329 - 52; PMID: 9338107
   PubMedGoogle Scholar
• Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446:758 - 64; http://dx.doi.org/10.1038/nature05690; PMID: 17344859
   PubMed Web of Science ®Google Scholar
• Richardson RB. Promotional etiology for common childhood acute lymphoblastic leukemia: the infective lymphoid recovery hypothesis. Leuk Res 2011; 35:1425 - 31; http://dx.doi.org/10.1016/j.leukres.2011.07.023; PMID: 21903265
   PubMed Web of Science ®Google Scholar
• Gazdar AF, Butel JS, Carbone M. SV40 and human tumours: myth, association or causality?. Nat Rev Cancer 2002; 2:957 - 64; http://dx.doi.org/10.1038/nrc947; PMID: 12459734
   PubMed Web of Science ®Google Scholar
• Harding C, Pompei F, Lee EE, Wilson R. Cancer suppression at old age. Cancer Res 2008; 68:4465 - 78; http://dx.doi.org/10.1158/0008-5472.CAN-07-1670; PMID: 18519710
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program. Cell Cycle 2010; 9:3151 - 6; http://dx.doi.org/10.4161/cc.9.16.13120; PMID: 20724817
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893 - 917; http://dx.doi.org/10.1002/ijc.25516; PMID: 21351269
   PubMed Web of Science ®Google Scholar
• Fast Stats: An interactive tool for access to SEER cancer statistics Bethesda MSRP, National Cancer Institute.
   Google Scholar
• Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 2007; 28:622 - 9; http://dx.doi.org/10.1002/humu.20495; PMID: 17311302
   PubMed Web of Science ®Google Scholar
• Porter AMW. Misuse of correlation and regression in three medical journals. J R Soc Med 1999; 92:123 - 8; PMID: 10396255
   PubMed Web of Science ®Google Scholar